Latest Parkinson's disease Stories
Lawrence LeBlond for redOrbit.com - Your Universe Online Health experts around the world are talking about a remarkable phenomenon seen in Parkinson’s patients that was first noticed by researchers at Tel Aviv University’s Sackler Faculty of Medicine over the holidays. Professor Rivka Inzelberg said patients she treated at Sheba Medical Center clinic had skipped bringing the usual presents of chocolate, flowers and knick-knacks in over the holiday season and had instead brought in...
Oxidative stress is a primary villain in a host of diseases that range from cancer and heart failure to Alzheimer’s disease, Amyotrophic Lateral Sclerosis and Parkinson’s disease. Now, scientists from the Florida campus of The Scripps Research Institute (TSRI) have found that blocking the interaction of a critical enzyme may counteract the destruction of neurons associated with these neurodegenerative diseases, suggesting a potential new target for drug development. These findings...
redOrbit Staff & Wire Reports - Your Universe Online The search for a diagnostic test for Parkinson’s disease may soon be over, as new research suggests that testing part of a patient’s saliva gland could detect the degenerative disorder. As part of a study released Thursday, Charles Adler of the Mayo Clinic in Arizona and colleagues recruited 15 Parkinson’s patients with an average age of 68. The study participants had dealt with the disease for an average of 12 years, had...
DANVILLE, Calif., Jan. 10, 2013 /PRNewswire/ -- While the Danville d'Elegance (DDE) Foundation takes great pride in its small town values, the organization is definitely going BIG in its efforts to support Parkinson's research and patient care - in fact, after only eight short years in existence, DDE has earned national recognition as the "Number One" fundraiser for Team Fox, the globally renowned grassroots community fundraising arm for The Michael J. Fox Foundation (MJFF),...
Specialized care for all major neurological disorders offered at new neuroscience facility at Saint Luke's hospital KANSAS CITY, Mo., Jan. 9, 2013 /PRNewswire-USNewswire/ -- Designed to serve as one of the preeminent neuroscience centers in the country, the Saint Luke's Neuroscience Institute tower officially opens today at Saint Luke's Hospital. The new facility, specializing in streamlined care for neurological disorders, offers the Kansas City community and the...
SUNNYVALE, Calif., Jan. 9, 2013 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company discovering and developing treatments and diagnostics for diseases associated with protein misfolding and apoptosis centered around its patented therapeutic protein Mesencephalic Astrocyte-derived Neurotrophic Factor (MANF), today presented positive preclinical efficacy data for MANF in a neurorestoration 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease. The...
Penn study suggests dopamine treatments may play role in increasing impulsivity While approximately one in five Parkinson's disease patients experience impulse control disorder symptoms, the disease itself does not increase the risk of gambling, shopping, or other impulsivity symptoms, according to research from the Perelman School of Medicine at the University of Pennsylvania. A new study is the first to show in a large sample that people with untreated Parkinson's were no more likely to...
Parkinson's disease itself does not increase the risk of impulse control problems such as compulsive gambling and shopping that have been seen in people taking certain drugs for Parkinson's disease, according to new research published in the January 8, 2013, print issue of Neurology®, the medical journal of the American Academy of Neurology. "We've known for some time that these behaviors are more common in people taking certain Parkinson's medications, but we haven't known if the disease...
Study suggests potential new target in fight against debilitating disease For several years, neurologists at UCLA have been building a case that a link exists between pesticides and Parkinson's disease. To date, paraquat, maneb and ziram — common chemicals sprayed in California's Central Valley and elsewhere — have been tied to increases in the disease, not only among farmworkers but in individuals who simply lived or worked near fields and likely inhaled drifting particles. Now,...
SUNNYVALE, Calif., Dec. 26, 2012 /PRNewswire/ -- Amarantus BioScience, Inc. (OTCQB: AMBS), a biotechnology company developing treatments and diagnostics for diseases associated with neurodegeneration and apoptosis, today announced the Company has purchased all of the intellectual property (IP) assets from Power3 Medical Products. Power3 was in bankruptcy, giving Amarantus the ability to acquire all of Power3's the IP for the diagnosis of multiple neurodegenerative diseases and...
